QQQ $ 604.92 $ 7.31 (1.22 %)
DIA $ 462.62 $ 3.26 (0.71 %)
SPY $ 665.19 $ 5.71 (0.87 %)
TLT $ 91.15 $ -0.08 (-0.08 %)
GLD $ 388.13 $ -9.01 (-2.27 %)
$ 0.67
-- x --
-- x --
-- - --
$ 0.52 - $ 0.89
23,367
na
6.95M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-28-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 04-26-2021 03-31-2021 10-Q
19 02-04-2021 12-31-2020 10-K
20 10-15-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-18-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-29-2019 12-31-2018 10-K
28 10-29-2018 09-30-2018 10-Q
29 07-23-2018 06-30-2018 10-Q
30 05-14-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 10-17-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-29-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-09-2016 12-31-2015 10-K
40 11-16-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 brainstorm-cell-q2-eps-034-beats-037-estimate

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.3...

 maxim-group-downgrades-brainstorm-cell-to-hold

Maxim Group analyst Jason McCarthy downgrades Brainstorm Cell (NASDAQ:BCLI) from Buy to Hold.

 brainstorm-cell-therapeutics-crashes-42-after-voluntary-nasdaq-delisting-announcement

BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced i...

 brainstorm-cell-therapeutics-files-prospectus-for-offer--sale-of-up-to-28m-shares-of-common-stock-by-selling-stockholder

https://www.sec.gov/Archives/edgar/data/1137883/000110465925062607/tm2518806d1_s3.htm

 brainstorm-announces-new-survival-data-from-expanded-access-program-of-nurown-in-als-90-of-participants-survived-more-than-five-yers-from-onset-of-als-symptoms

Key findings include:90% of participants (9/10) survived more than five years from the onset of ALS symptoms, compared to publi...

Core News & Articles
Market-Moving News for May 19th
05/19/2025 11:16:14

BCLI: 120% | BrainStorm Cell Therapeutics shares are trading higher after the company received FDA clearance to initiate its Ph...

 brainstorm-cell-q1-eps-045-beats-097-estimate

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.9...

 brainstorm-to-present-pharmacogenomic-data-on-nurown-at-isct-2025-highlighting-unc13a-genotype-in-amyotrophic-lateral-sclerosis

New findings highlight impact of UNC13A genotype on treatment response in ALS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION